Xianjiang Kang Selected Research

tracheloside

9/2022

Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianjiang Kang Research Topics

Disease

4	Lung Neoplasms (Lung Cancer) 09/2022 - 10/2021
4	Neoplasms (Cancer) 07/2022 - 01/2021
2	Adenocarcinoma of Lung 09/2022 - 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Fibrosis (Cirrhosis) 03/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2015
1	Alzheimer Disease (Alzheimer's Disease) 02/2012
1	Wounds and Injuries (Trauma) 06/2011

Drug/Important Bio-Agent (IBA)

3	Annexin A5IBA 07/2022 - 01/2021
3	Pharmaceutical PreparationsIBA 03/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2022
1	trachelosideIBA 09/2022
1	Drug CombinationsIBA 09/2022
1	caffeic acidIBA 07/2022
1	Coffee FDA Link 07/2022
1	Sincalide FDA Link 07/2022
1	nuciferineIBA 03/2022
1	Cisplatin (Platino)FDA LinkGeneric 03/2022
1	HomoharringtonineIBA 10/2021
1	Cyclin D1IBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Silybin (Lagosa)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Ursolic AcidIBA 03/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2012
1	CytokinesIBA 06/2011

Therapy/Procedure

3	Therapeutics 07/2022 - 01/2021
1	Drug Therapy (Chemotherapy) 09/2022
1	Diet Therapy (Therapy, Diet) 07/2022
1	Ligation 03/2015
1	Transplantation 02/2012